+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antipsychotic Drug"

Tardive Dyskinesia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Tardive Dyskinesia Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 240 Pages
  • Global
From
Tourettes Syndrome Drugs - Global Strategic Business Report - Product Thumbnail Image

Tourettes Syndrome Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 274 Pages
  • Global
From
From
Prion Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Prion Disease Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 268 Pages
  • Global
From
Bipolar Disorder Treatment - Global Strategic Business Report - Product Thumbnail Image

Bipolar Disorder Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 387 Pages
  • Global
From
From
Delirium - Global Strategic Business Report - Product Thumbnail Image

Delirium - Global Strategic Business Report

  • Report
  • September 2025
  • 281 Pages
  • Global
From
Depression Drugs - Global Strategic Business Report - Product Thumbnail Image

Depression Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 380 Pages
  • Global
From
Frontotemporal Dementia - Global Strategic Business Report - Product Thumbnail Image

Frontotemporal Dementia - Global Strategic Business Report

  • Report
  • September 2025
  • 381 Pages
  • Global
From
Postpartum Depression Drugs - Global Strategic Business Report - Product Thumbnail Image

Postpartum Depression Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 479 Pages
  • Global
From
Tourette Syndrome Treatment - Global Strategic Business Report - Product Thumbnail Image

Tourette Syndrome Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 186 Pages
  • Global
From
From
From
Schizophrenia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Schizophrenia Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 197 Pages
  • Global
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 898 Pages
  • Global
From
Bipolar Disorder Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Bipolar Disorder Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 380 Pages
  • Global
From
From
Anxiety Disorder Treatment - Global Strategic Business Report - Product Thumbnail Image

Anxiety Disorder Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 196 Pages
  • Global
From
Tourette Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Tourette Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Antipsychotic Drug market is a segment of the Central Nervous System Drugs market. Antipsychotic drugs are used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. These drugs work by blocking dopamine receptors in the brain, which helps to reduce the symptoms of psychosis. Common side effects of antipsychotic drugs include drowsiness, weight gain, and dry mouth. The Antipsychotic Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Eli Lilly, Pfizer, Johnson & Johnson, Novartis, and AstraZeneca. These companies have a wide range of products, including both branded and generic drugs. Additionally, many of these companies have developed new formulations of existing drugs, such as long-acting injectables, to improve patient compliance. Show Less Read more